Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma.
Kie NakataniSatoshi SeradaMinoru FujimotoKengo ObataTomoharu OhkawaraEri SasabeTetsuya YamamotoTetsuji NakaPublished in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2021)
SOCS1 gene therapy may be a beneficial approach for the treatment of OSCC.